Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein ε4 on memory decline in older adults

Erin Elizabeth Sundermann, Cuiling Wang, Mindy Joy Katz, Molly E. Zimmerman, Carol A. Derby, Charles B. Hall, Laurie J. Ozelius, Richard B. Lipton

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Apolipoprotein ε4 (ApoE4) is a strong genetic risk factor for sporadic Alzheimer's disease and memory decline in older adults. A single-nucleotide polymorphism in the cholesteryl ester transfer protein (CETP) gene (isoleucine to valine; V405) is associated with slower memory decline and a lower risk of Alzheimer's disease. As both genes regulate cholesterol, we hypothesized that the favorable CETPV405 allele may buffer the effect of ApoE4 on memory decline in older adults. Using linear regression, we examined the interactive effect of ApoE4 by CETPV405 on memory decline among 909 community-dwelling, nondemented, older adults (≥70 years) from the Einstein Aging Study. Episodic memory was measured using the picture version of the Free and Cued Selective Reminding Test with immediate recall (pFCSRT+IR). There was a significant ApoE × CETP interaction on decline in pFCSRT+IR scores (p = 0.01). ApoE4 carriers experienced faster decline than noncarriers among CETPI405I homozygotes (p = 0.007) and in CETPI405V heterozygotes (p = 0.015) but not in CETPV405V homozygotes (p = 0.614). Results suggest that the CETPV405 allele buffers ApoE4-associated memory decline in a gene dose-dependent manner.

Original languageEnglish (US)
Pages (from-to)200.e7-200.e12
JournalNeurobiology of Aging
Volume41
DOIs
StatePublished - May 1 2016

Fingerprint

Cholesterol Ester Transfer Proteins
Apolipoproteins
Genotype
Homozygote
Alzheimer Disease
Buffers
Alleles
Genes
Independent Living
Episodic Memory
Isoleucine
Valine
Apolipoproteins E
Heterozygote
Short-Term Memory
Single Nucleotide Polymorphism
Linear Models
Cholesterol

Keywords

  • ApoE ε4
  • CETP
  • Gene-gene interaction
  • I405V
  • Memory decline

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein ε4 on memory decline in older adults. / Sundermann, Erin Elizabeth; Wang, Cuiling; Katz, Mindy Joy; Zimmerman, Molly E.; Derby, Carol A.; Hall, Charles B.; Ozelius, Laurie J.; Lipton, Richard B.

In: Neurobiology of Aging, Vol. 41, 01.05.2016, p. 200.e7-200.e12.

Research output: Contribution to journalArticle

@article{e5c9aa9e36534c789471fa9e47182236,
title = "Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein ε4 on memory decline in older adults",
abstract = "Apolipoprotein ε4 (ApoE4) is a strong genetic risk factor for sporadic Alzheimer's disease and memory decline in older adults. A single-nucleotide polymorphism in the cholesteryl ester transfer protein (CETP) gene (isoleucine to valine; V405) is associated with slower memory decline and a lower risk of Alzheimer's disease. As both genes regulate cholesterol, we hypothesized that the favorable CETPV405 allele may buffer the effect of ApoE4 on memory decline in older adults. Using linear regression, we examined the interactive effect of ApoE4 by CETPV405 on memory decline among 909 community-dwelling, nondemented, older adults (≥70 years) from the Einstein Aging Study. Episodic memory was measured using the picture version of the Free and Cued Selective Reminding Test with immediate recall (pFCSRT+IR). There was a significant ApoE × CETP interaction on decline in pFCSRT+IR scores (p = 0.01). ApoE4 carriers experienced faster decline than noncarriers among CETPI405I homozygotes (p = 0.007) and in CETPI405V heterozygotes (p = 0.015) but not in CETPV405V homozygotes (p = 0.614). Results suggest that the CETPV405 allele buffers ApoE4-associated memory decline in a gene dose-dependent manner.",
keywords = "ApoE ε4, CETP, Gene-gene interaction, I405V, Memory decline",
author = "Sundermann, {Erin Elizabeth} and Cuiling Wang and Katz, {Mindy Joy} and Zimmerman, {Molly E.} and Derby, {Carol A.} and Hall, {Charles B.} and Ozelius, {Laurie J.} and Lipton, {Richard B.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.neurobiolaging.2016.02.006",
language = "English (US)",
volume = "41",
pages = "200.e7--200.e12",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein ε4 on memory decline in older adults

AU - Sundermann, Erin Elizabeth

AU - Wang, Cuiling

AU - Katz, Mindy Joy

AU - Zimmerman, Molly E.

AU - Derby, Carol A.

AU - Hall, Charles B.

AU - Ozelius, Laurie J.

AU - Lipton, Richard B.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Apolipoprotein ε4 (ApoE4) is a strong genetic risk factor for sporadic Alzheimer's disease and memory decline in older adults. A single-nucleotide polymorphism in the cholesteryl ester transfer protein (CETP) gene (isoleucine to valine; V405) is associated with slower memory decline and a lower risk of Alzheimer's disease. As both genes regulate cholesterol, we hypothesized that the favorable CETPV405 allele may buffer the effect of ApoE4 on memory decline in older adults. Using linear regression, we examined the interactive effect of ApoE4 by CETPV405 on memory decline among 909 community-dwelling, nondemented, older adults (≥70 years) from the Einstein Aging Study. Episodic memory was measured using the picture version of the Free and Cued Selective Reminding Test with immediate recall (pFCSRT+IR). There was a significant ApoE × CETP interaction on decline in pFCSRT+IR scores (p = 0.01). ApoE4 carriers experienced faster decline than noncarriers among CETPI405I homozygotes (p = 0.007) and in CETPI405V heterozygotes (p = 0.015) but not in CETPV405V homozygotes (p = 0.614). Results suggest that the CETPV405 allele buffers ApoE4-associated memory decline in a gene dose-dependent manner.

AB - Apolipoprotein ε4 (ApoE4) is a strong genetic risk factor for sporadic Alzheimer's disease and memory decline in older adults. A single-nucleotide polymorphism in the cholesteryl ester transfer protein (CETP) gene (isoleucine to valine; V405) is associated with slower memory decline and a lower risk of Alzheimer's disease. As both genes regulate cholesterol, we hypothesized that the favorable CETPV405 allele may buffer the effect of ApoE4 on memory decline in older adults. Using linear regression, we examined the interactive effect of ApoE4 by CETPV405 on memory decline among 909 community-dwelling, nondemented, older adults (≥70 years) from the Einstein Aging Study. Episodic memory was measured using the picture version of the Free and Cued Selective Reminding Test with immediate recall (pFCSRT+IR). There was a significant ApoE × CETP interaction on decline in pFCSRT+IR scores (p = 0.01). ApoE4 carriers experienced faster decline than noncarriers among CETPI405I homozygotes (p = 0.007) and in CETPI405V heterozygotes (p = 0.015) but not in CETPV405V homozygotes (p = 0.614). Results suggest that the CETPV405 allele buffers ApoE4-associated memory decline in a gene dose-dependent manner.

KW - ApoE ε4

KW - CETP

KW - Gene-gene interaction

KW - I405V

KW - Memory decline

UR - http://www.scopus.com/inward/record.url?scp=84963594599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963594599&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2016.02.006

DO - 10.1016/j.neurobiolaging.2016.02.006

M3 - Article

C2 - 27033407

AN - SCOPUS:84963594599

VL - 41

SP - 200.e7-200.e12

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

ER -